| Question 13 | Rocuronium vs. suxamethonium |
| Question 12 | Excitation-contraction coupling in smooth muscle |
| Question 6 | Pharmacology of vecuronium |
| Question 10 | Depolarising neuromuscular jucntion blockers: pharmacology of suxamethonium |
| Question 3 | Relationship between muscle length and tension |
| Question 17 | .Physiology of neuromuscular transmission. |
| Question 13 | Rocuronium vs. cisatracurium |
| Question 10 | Pharmacology of suxamethonium |
| Question 12 | Speed of onset of neuromuscular blockade |
| Question 11 | Anatomy and physiology of muscle: skeletal vs. smooth. |
| Question 7 | Pharmacology of NMJ blockers: factors which potentiate them |
| Question 9 | Factors that influence the speed of onset of neuromuscular blockade |
| Question 8 | Physiology of skeletal muscle cell contraction |
| Question 1 | Pharmacology of neuromuscular junction blockers: suxamethonium |
| Question 2 | Pharmacology of neuromuscular junction blockers: suxamethonium |
| Question 18 | Smooth muscle excitation-contraction coupling |
| Question 6 | Pharmacology of neuromuscular junction blockers: suxamethonium |
| Question 3 | Pharmacology of neuromuscular junction blockers: speed of onset |
| Question 1 | Factors which alter the response to neuromuscular junction blockers |